Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON27284Active, not recruiting
Randomised, double-blind trial of methylphenidate in attention deficit hyperactivity disorder (ADHD) (2 arms), sponsored by Radboud University. Primary endpoints: Alpha Lateralization Index, Alpha Modulation Index and 4 more. Started Oct 2016; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON27284.